XML 63 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Financial expenses, net (Tables)
 12 Months Ended
Dec. 31, 2022
Schedule of Financial Expenses
 
 
  
Year ended December, 31
 
 
  
  2022  
 
  
  2021  
 
  
  2020  
 
 
  
(U.S. $ in millions)
 
Interest expenses and other bank charges
      930        891        901  
(Income) loss from investments (1)
      (10 )       90        (104 )
Foreign exchange (gains) losses, net
      (16 )       7        (26 ) 
Other, net (2)
      61        71        62  
    
 
 
     
 
 
     
 
 
  
Total finance expense, net
    $     966      $ 1,058      $ 834  
    
 
 
     
 
 
     
 
 
  
 
(1)
(Income) loss from investments in 2021 and 2020 comprised mainly of revaluation gains and loss of Teva’s investment in American Well Corporation (“American Well”).
(2)
Amortization of issuance costs and terminated derivative instruments.